Themis Medicare's Stock Reaches 52-Week High, Outperforms Sector by 6.81%

Sep 25 2024 02:05 PM IST
share
Share Via
Themis Medicare, a smallcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high on September 25th, 2024. The stock has been given a 'Hold' rating by MarketsMojo and has outperformed the sector by 6.81%. With a positive trend in its performance and a strong 64.76% increase in the past year, the company shows potential for growth in the pharmaceutical industry.

Themis Medicare, a smallcap pharmaceutical company, has recently seen a surge in its stock price, reaching a 52-week high on September 25th, 2024. The stock has been given a 'Hold' rating by MarketsMOJO, a leading financial analysis platform.

The company's stock has been performing well, outperforming the sector by 6.81% on the day of the price surge. This marks a trend reversal for the stock, which had seen two consecutive days of falling prices.

On the day of the price surge, the stock reached an intraday high of Rs. 291, a 6.59% increase from the previous day's close. However, it also touched an intraday low of Rs. 267.45, showing some volatility in its trading.

Themis Medicare's stock is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its performance.

In the past year, Themis Medicare has shown a strong performance, with a 64.76% increase in its stock price, compared to the Sensex's 28.68% performance. This showcases the company's potential for growth and success in the pharmaceutical industry.

As a smallcap company, Themis Medicare has shown promising growth and potential, making it an attractive investment option for investors. With its recent surge in stock price and positive performance, it will be interesting to see how the company continues to grow and evolve in the future.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News